Use of plerixafor in patients with Hodgkin lymphoma with poor mobilization of peripheral blood stem cells

Leuk Lymphoma. 2013 Mar;54(3):646-8. doi: 10.3109/10428194.2012.713480. Epub 2012 Aug 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antigens, CD34 / blood
  • Benzylamines
  • Cell Count
  • Cyclams
  • Female
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Hematopoietic Stem Cell Mobilization / methods*
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / metabolism
  • Heterocyclic Compounds / pharmacology*
  • Hodgkin Disease / blood*
  • Hodgkin Disease / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Stem Cell Transplantation / methods
  • Transplantation, Autologous
  • Young Adult

Substances

  • Antigens, CD34
  • Benzylamines
  • Cyclams
  • Heterocyclic Compounds
  • Granulocyte Colony-Stimulating Factor
  • plerixafor